The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Integration of metabolic flux with hepatic glucagon signaling and gene expression profiles in the conscious dog
Open accessPublished version of a preprint
Abstract
Glucagon rapidly stimulates hepatic glucose production, but these effects are transient. This study links the molecular and metabolic flux changes that occur in the liver over time in response to a rise in glucagon, demonstrating the strength of the dog as a translational model to couple findings in small animals and humans. In addition, this study clarifies why the rapid effects of glucagon on liver glycogen metabolism are not sustained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Coate and Ramnanan investigated the molecular and metabolic flux changes occurring in the liver in response to a rise in glucagon, clarifying why the glucagon effect is not sustained.
“More recently, Coate and Ramnanan investigated the molecular and metabolic flux changes occurring in the liver in response to a rise in glucagon, clarifying why the glucagon effect is not sustained [21].”
From Modeling the effect of glucagon on endogenous glucose production in healthy individuals under meal-like conditions (2025) · cites this paper as [21]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670
Self-citationHormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429
Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Rizza, R. A., Cryer, P. E., & Gerich, J. E. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109464 · Cited by 421 · cited 1×
“3 Introduction 45 Stimulation of hepatic glucose production (HGP) by glucagon is critical to the regulation of 46 glucose homeostasis during fasting (62), exercise (63), trauma and infection (53), and hypoglycemia 47 (8, 47, 50).”
BackgroundPathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
Rizza, R. A. (2010) · Diabetes · doi:10.2337/db10-1032 · Cited by 367
The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting
Longuet, C., Sinclair, E. M., Maida, A., Baggio, L. L., Maziarz, M., Charron, M. J., & Drucker, D. J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.09.008 · Cited by 272
Ros, S., & Schulze, A. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-8 · Cited by 269
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
Cryer, P. E. (2012) · Endocrinology · doi:10.1210/en.2011-1499 · Cited by 242
The extracellular matrix and insulin resistance
Williams, A. S., Kang, L., & Wasserman, D. H. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.006 · Cited by 228 · cited 4×
“abundance and composition to maintain tissue homeostasis in response to injury (40, 64).”
BackgroundInfluentialGlucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis
Perry, R. J., Zhang, D., Guerra, M. T., Brill, A. L., Goedeke, L., Nasiri, A. R., Rabin-Court, A., Wang, Y., Peng, L., Dufour, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2074-6 · Cited by 186
Inactivating hepatic follistatin alleviates hyperglycemia
Tao, R., Wang, C., Stöhr, O., Qiu, W., Hu, Y., Miao, J., Dong, X. C., Leng, S., Stefater, M., Stylopoulos, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0048-0 · Cited by 104
Flagged first, then by citations
Research works printed but not linked: 69
- 10.1172/JCI108641 · DOI
- 10.1152/ajpendo.1989.257.1.E108 · DOI · Paper page
- 10.5152/UCD.2014.265 · DOI
- 10.1152/ajpendo.1989.256.5.E651 · DOI
- 10.2337/diab.28.6.533 · DOI
- 10.1016/s0140-6736(75)92375-2 · DOI · Paper page
- 10.1152/ajpendo.90887.2008 · DOI
- 10.1016/j.amjmed.2009.12.008 · DOI
- 10.2337/db09-1625 · DOI
- 10.1172/JCI45472 · DOI
- 10.1016/0014-5793(79)80515-3 · DOI
- 10.1042/BJ20111416 · DOI
- 10.1016/S0021-9258(19)75689-0 · DOI
- 10.1016/0003-2697(68)90127-9 · DOI
- 10.1210/jendso/bvab088 · DOI
- 10.1111/j.2517-6161.1995.tb02031.x · DOI · Paper page
- 10.1016/j.cels.2015.12.004 · DOI · Paper page
- 10.2337/diabetes.50.8.1872 · DOI
- 10.2337/diabetes.53.1.32 · DOI
- 10.2337/diabetes.51.6.1663 · DOI
- 10.1016/s0169-2607(02)00097-4 · DOI
- 10.1146/annurev.nu.16.070196.001143 · DOI · Paper page
- 10.1016/j.molmet.2023.101703 · DOI
- 10.7554/eLife.69521 · DOI
- 10.1101/cshperspect.a014225 · DOI
- 10.1093/lifemeta/load021 · DOI
- 10.2337/diab.31.10.917 · DOI
- 10.2337/diabetes.30.3.180 · DOI
- 10.1016/s0026-0495(96)90223-1 · DOI
- 10.1042/BJ20080595 · DOI
- 10.1146/annurev-nutr-071715-051145 · DOI
- 10.1074/jbc.275.14.10597 · DOI
- 10.1096/fasebj.8.6.8168691 · DOI
- 10.2337/diabetes.52.6.1333 · DOI
- 10.1042/BJ20031191 · DOI
- 10.1042/bj3360019 · DOI
- 10.1002/dmr.5610030107 · DOI
- 10.1096/fasebj.11.7.9212078 · DOI
- 10.2337/db13-0880 · DOI
- 10.1146/annurev.bi.57.070188.003543 · DOI
- 10.1038/nm.3202 · DOI
- 10.1016/s0026-0495(76)80140-0 · DOI
- 10.1172/JCI107537 · DOI
- 10.14814/phy2.15263 · DOI
- 10.1016/j.cmet.2012.03.002 · DOI
- 10.1016/j.molmet.2013.11.007 · DOI
- 10.1038/nm.3115 · DOI
- 10.1152/ajpendo.00304.2022 · DOI
- 10.1042/0264-6021:3620513 · DOI
- 10.1111/j.1432-1033.1983.tb07784.x · DOI
- 10.1016/0026-0495(72)90028-5 · DOI
- 10.1210/jc.86.5.2085 · DOI
- 10.1210/jcem-72-2-308 · DOI
- 10.1007/s00125-012-2464-x · DOI
- 10.1172/jci38650 · DOI
- 10.1016/j.mce.2012.06.018 · DOI
- 10.1172/JCI40919 · DOI
- 10.1111/j.1463-1326.2011.01454.x · DOI · Paper page
- 10.1016/S0021-9258(20)82102-4 · DOI
- 10.1152/ajpendo.1982.242.2.E73 · DOI
- 10.1152/ajpendo.00466.2019 · DOI
- 10.2337/dbi22-0002 · DOI
- 10.1016/j.cmet.2017.05.011 · DOI
- 10.1016/j.isci.2022.105296 · DOI
- 10.1016/j.celrep.2015.06.034 · DOI
- Haynes RC, 1974, Mol Pharmacol, 10, 381
- 10.1016/0003-9861(75)90422-1 · DOI
- 10.2337/db17-1502 · DOI · Paper page
- 10.2337/db20-7-LB · DOI
Cited by
Sorted by citations
Faggionato, E., Tonello, A., Laurenti, M. C., Vella, A., & Dalla Man, C. (2025) · American Journal of Physiology - Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00172.2025
Metadata
- Authors
- Coate, K. C., Ramnanan, C. J., Smith, M., Winnick, J. J., Kraft, G., Irimia-Dominguez, J., Farmer, B., Donahue, E. P., Roach, P. J., Cherrington, A. D., & Edgerton, D. S.
- Affiliations
- Vanderbilt University Medical Center (US)
- University of Ottawa (CA)
- Vanderbilt University (US)
- University of Cincinnati (US)
- Department of Molecular and Cellular Endocrinology, Beckman Research Institute, Duarte, California, United States
- Indiana University School of Medicine (US)
- Corresponding author
- Edgerton, Dale S.
- ORCID
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2024-04-01
- Volume
- 326
- Issue
- 4
- Pages
- E428-E442
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- PMC
- PMC11193521
- OpenAlex
- W4391616236
- Cited by
- 7
- References
- 11
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK18243, SP-60-AM20593, DK20593)
- American Diabetes Association (Mentor-based Fellowship)
- Vanderbilt Jacquelyn A. Turner and Dr. Dorothy J. Turner Chair in Diabetes Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- glucagon signaling, hepatic glucose production, metabolic flux, liver glycogen metabolism, gene expression profiles, canine model, translational model, hepatic glucose metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review